Thus, we speculate that whether it is possible to check up-regulation in mRNA expression no modifications can be described on protein expression levels. Herein, T or I treatment increased Glut4 mRNA, but not protein expression. Principally, I activates the p21ras/MAP kinase (MAPK) (RAS)/extracellular-signal-regulated kinase (ERK) and the Phosphoinositide 3-kinase (PI3 K)/AKT pathways known to play different role in I-mediated effects. To date, 14 glucose transporters isoforms with a specific pattern of tissue expression have been identified . GLUT4 mediates glucose uptake in adipose tissues and striated muscle. Thus, T, for many years considered the "male hormone" with a "muscular hypertrophying function" seems to influence glucose metabolism independently by gender. Effect of bicalutamide on Testosterone-induced I-related metabolic pathways. Western blot (Fig. 5) showed that Bic pre-treatment significantly counteracted T-related phosphorylation/activation of AKT, ERK1/2, mTOR and GSK3β signaling transduction pathways (P P 5a–d). 1-h pre-treatment with Bic 100 nM completely counteracted T-induced GLUT4 translocation. Furthermore, AR antagonism by Bic reduced GLUT4 signal basal levels (Fig. 4a, upper panels). Immunofluorescence for GLUT4 revealed that Bic pre-treatment counteracted the GLUT4 signal immunodecoration induced by T (Fig. 4a, upper panels). Similar results were observed in non-permeabilized differentiated Hfsmc (differentiated), where positive specific staining for GLUT4 was stronger after T or I vs. control (Fig. 2a, upper panels, differentiated). Sebaceous glands and hair follicles are highly androgen-sensitive tissues. Even when blood levels appear "normal," tissue sensitivity can be increased. Testosterone increases haematocrit by suppressing hepcidin and increasing expression of ferroportin along with that of transferrin receptor and plasma transferrin concentrations. The role of testosterone in improving sexual symptoms in men with hypogonadism is well known. The pre-treatment with bicalutamide (100… Effect of bicalutamide pre-treatment on… Glut1, Glut3 and Glut4 mRNA expression was evaluated in undifferentiated or differentiated Hfsmc treated for 24 h with T (100 nM) or I (100 nM) for comparison. Experiments were performed three times with different cell preparations. Cells in serum-free medium with 0.1% BSA and vehicle were used as controls. Western blot analysis was performed in three/four independent experiments with different cell preparations. Androgen receptor antagonism was obtained by pre-treating Hfsmc with 100 nM of bicalutamide for 1 h before T treatments. Cells in serum-free medium with 0.1% BSA and vehicle were used as control. Cells were isolated from 11 fetal skeletal male muscles (four upper and seven lower limbs) obtained after voluntary abortion (10–12 weeks of gestation to set up fetal tissue sample collection previously used ). Shaded area represents values for subjects with hypogonadal testosterone levels (i.e., 2 max) (C) and expression of UQCRB in skeletal muscle (D). Correlation between insulin sensitivity (M) and serum testosterone (T) levels (A) and SHBG levels (B) in 60 men; 27 had NGT (□), 12 had IGT (△), and 21 had type 2 diabetes (•). In terms of addressing causality, it has been shown that improving insulin sensitivity by losing weight, whether by lifestyle changes or bariatric surgery, results in a significant increase in total testosterone levels (17). We and others have shown that testosterone levels are significantly lower in men with impaired glucose tolerance and T2DM than in normoglycemic controls (16). Men with hypogonadal testosterone levels were twice as insulin resistant as eugonadal controls. Given that low testosterone levels predict type 2 diabetes mellitus (T2DM) in men, we sought to dissect the relationship between testosterone and insulin sensitivity in men. In females, excess testosterone action via AR in β cells promotes insulin hypersecretion leading to oxidative injury, which in turn predisposes to T2D. In summary, the hormonal, metabolic, and body composition changes following correction of extreme hyperandrogenism in this patient indicate that testosterone may improve insulin sensitivity both directly and through changes in body composition. In conclusion, testosterone exerts a series of potent metabolic effects, which include insulin sensitization, maintenance and growth of the skeletal muscle, suppression of adipose tissue growth and maintenance of erythropoiesis and haematocrit.